M&A advisor fees · SEC filings 2023–2026
How much do M&A advisors charge?
Across 626 US merger proxies and tender-offer statements filed 2023–2026, target-side advisor fees fell from a median of 5.9% of deal value on deals under $50M to 0.9% on deals over $5B.
The fairness-opinion portion, paid when the opinion is delivered, had a median of $2.0M across 513 disclosures. Every fee below links to the sentence in the filing that states it.
Fees by deal size
In 108 disclosed deals valued $1–5B, target-side advisor fees had a median of 1.89% of deal value; in 19 deals under $50M the median was 5.90%, and in 57 deals above $5B it was 0.94% (SEC filings, 2023–2026).
Sum of every target-side advisor's fee in each deal, divided by deal value. Deal value is the aggregate consideration stated in the filing or, where none is stated, the cash price per share × shares outstanding. SPAC mergers and deals whose two value measures disagree by more than 2× are excluded.
| Deal value | Deals | Median fee | Median % of value | Middle half | Median opinion fee |
|---|---|---|---|---|---|
| Under $50M | 19 | $1.66M | 5.90% | 2.83%–9.05% | $1M |
| $50–100M | 22 | $2.5M | 3.44% | 1.25%–4.96% | $1M |
| $100–250M | 30 | $3.95M | 2.27% | 1.46%–3.82% | $1M |
| $250–500M | 36 | $10.3M | 3.00% | 1.75%–4.23% | $1.25M |
| $500M–1B | 43 | $15.7M | 2.24% | 1.68%–2.92% | $2M |
| $1–5B | 108 | $37M | 1.89% | 1.37%–2.36% | $2.5M |
| $5B+ | 57 | $90M | 0.94% | 0.55%–1.26% | $4M |
Fees by firm
Goldman Sachs disclosed 83 fees with a median of $33M (1.17% of deal value), Centerview Partners 81 with a median of $35M (1.75%), and J.P. Morgan 68 with a median of $23M (1.09%) in 2023–2026 SEC filings. By tier, a single elite-boutique advisor's fee had a median of 1.75% of deal value across 109 disclosures, against 1.25% across 156 for bulge-bracket banks.
Firms with two or more disclosed fees. Tier follows the public lists described in the advisor directory; a firm is placed on the first list it appears on.
| Firm | Tier | Fee disclosures | Median fee | Median % of value | Median opinion fee |
|---|---|---|---|---|---|
 Goldman Sachs | Bulge bracket | 83 | $33M | 1.17% | $2M |
| Centerview Partners | Elite boutique | 81 | $35M | 1.75% | $2M |
 J.P. Morgan | Bulge bracket | 68 | $23M | 1.09% | $3M |
 BofA Securities | Bulge bracket | 48 | $18.1M | 1.07% | $2M |
 Morgan Stanley | Bulge bracket | 43 | $37M | 1.53% | $5M |
 Jefferies | Middle market | 32 | $23.8M | 1.43% | $2M |
 Citi | Bulge bracket | 23 | $21M | 1.44% | $2.75M |
| Leerink Partners | Not on a tier list | 22 | $3M | 2.75% | $1M |
 Evercore | Elite boutique | 21 | $20M | 1.55% | $2M |
 Houlihan Lokey | Middle market | 21 | $2.2M | 1.85% | $875K |
 TD Cowen | Middle market | 17 | $3M | 3.82% | $1M |
 Lazard | Elite boutique | 16 | $20M | 2.05% | $2M |
 Wells Fargo Securities | Not on a tier list | 14 | $27.9M | 1.02% | $4M |
 Guggenheim Securities | Elite boutique | 13 | $11.2M | 1.12% | $2.25M |
 Piper Sandler | Middle market | 12 | $3M | 2.17% | $875K |
 PJT Partners | Elite boutique | 11 | $26.2M | 0.70% | $5M |
 Kroll | Middle market | 9 | $575K | 0.43% | $243K |
 Keefe, Bruyette & Woods | Not on a tier list | 8 | $3.63M | 1.29% | $500K |
 Perella Weinberg Partners | Elite boutique | 8 | $5M | 2.12% | $1.5M |
 Truist Securities | Middle market | 8 | $7.7M | 1.75% | $1M |
 Raymond James | Middle market | 7 | $2.25M | 1.26% | $350K |
| Newbridge | Not on a tier list | 7 | $75K | — | $45K |
 Moelis & Company | Elite boutique | 6 | $19.5M | 2.12% | $2.25M |
| Allen & Company | Not on a tier list | 6 | $37.5M | 0.13% | $7.75M |
 William Blair | Middle market | 5 | $1M | 0.62% | $1M |
 Stifel | Middle market | 4 | $1.75M | 5.88% | $1.5M |
 BMO | Not on a tier list | 4 | $15.5M | — | $4.75M |
 UBS | Bulge bracket | 4 | $18.3M | 176.98% | $2.5M |
 Rothschild | Elite boutique | 4 | $14.7M | 1.77% | $2.75M |
 Roth Capital Partners | Not on a tier list | 4 | $230K | 17.82% | $263K |
| Chestnut | Not on a tier list | 3 | $4M | 0.35% | — |
 Craig-Hallum | Not on a tier list | 3 | $500K | 3.70% | $300K |
 Chardan | Not on a tier list | 3 | $6.81M | 83.33% | — |
| Rbccm | Not on a tier list | 3 | $4M | 1.70% | $4.5M |
| Ft | Not on a tier list | 3 | $11.3M | 2.06% | $1.13M |
| Scalar | Not on a tier list | 2 | $118K | — | $85K |
 RBC Capital Markets | Not on a tier list | 2 | $6.75M | 0.20% | $1.5M |
| Intrinsic | Not on a tier list | 2 | $200K | 0.20% | — |
 Barclays | Bulge bracket | 2 | $45.5M | 0.77% | $3M |
| Btig | Not on a tier list | 2 | $1M | 0.92% | $500K |
| Mts | Not on a tier list | 2 | $2.5M | — | $2.5M |
| Gordon Dyal | Not on a tier list | 2 | $45M | — | — |
| Santander | Not on a tier list | 2 | $5M | 11.10% | — |
| Lincoln | Middle market | 2 | $1.4M | — | — |
| Qatalyst Partners | Elite boutique | 2 | $83.5M | 0.51% | $6.25M |
| IBI Corporate Finance | Not on a tier list | 2 | $435K | 2.72% | — |
| Focus | Lower middle market | 2 | $880K | 2.93% | — |
| Intrepid | Not on a tier list | 2 | $250K | 0.15% | $875K |
| Stephens | Middle market | 2 | $6.25M | 0.70% | — |
| Macquarie | Not on a tier list | 2 | $9.8M | 7.06% | $1.25M |
| Kidron | Not on a tier list | 2 | $275K | 4.74% | $150K |
| Solomon | Not on a tier list | 0 | — | — | $2.25M |
| LionTree | Not on a tier list | 2 | $31.5M | — | $8M |
| Jll | Not on a tier list | 2 | $3.33M | 0.80% | $400K |
A named firm’s figures are what it was paid on the specific engagements disclosed in these filings. They are not the firm’s rate card, the firm may charge differently on other work, and inclusion here does not imply any endorsement by or affiliation with the firm.
Every disclosed fee
Hover over a fee to see the sentence it comes from. The line under each advisor shows which side of the deal it advised.
760 rows
| Target | Advisor | Deal value | Total fee | Opinion fee | Source |
|---|---|---|---|---|---|
| Supernus Pharmaceuticals, Inc.acquired by Indivior | Jefferiesadvising the acquirer | — | $27.5M | — | DEFM14ASep 2026 |
| Supernus Pharmaceuticals, Inc.acquired by Indivior | Piper Sandleradvising the acquirer | — | $27.5M | $1.5M | DEFM14ASep 2026 |
| Supernus Pharmaceuticals, Inc.acquired by Indivior |  Cantor Fitzgeraldadvising the target | — | $30M | $2M | DEFM14ASep 2026 |
| Atkore Inc.acquired by Prysmian | Citiadvising the target | $2.6Bcomputed | $38M | $2.5M | DEFM14ASep 2026 |
| Atkore Inc.acquired by Prysmian | J.P. Morganadvising the target | $2.6Bcomputed | $21.5M | $3M | DEFM14ASep 2026 |
| Lantheus Holdings, Inc.acquired by CapVest | Morgan Stanleyadvising the target | $6.69Bcomputed | $81M | $10.5M | DEFM14ASep 2026 |
| Sanara MedTech Inc.acquired by MiMedx | Truist Securitiesadvising the target | $4.82Bcomputed | $6.1M | — | DEFM14ASep 2026 |
| Biolife Solutions Inc.acquired by Repligen | Centerview Partnersadvising the target | $1.58Bstated | $25M | $1M | DEFM14ASep 2026 |
| Roku, Inc.acquired by Fox | Allen & Companyadvising the acquirer | — | $55M | $5.5M | DEFM14ASep 2026 |
| Caesars Entertainment, Inc.acquired by Fei | PJT Partnersadvising the target | $6.32Bcomputed | $35M | $5M | DEFM14AAug 2026 |
| LogicMark, Inc. | Roth Capital Partnersadvising the target | $1.18Mcomputed | $210K | — | DEFM14AAug 2026 |
| Theravance Biopharma, Inc. | Lazardadvising the target | $883Mcomputed | $23M | $2M | DEFM14AAug 2026 |
| BIO-TECHNE Corp | Goldman Sachsadvising the target | $11.3Bstated | $106M | — | DEFM14AAug 2026 |
| First Real Estate Investment Trust Of New Jersey, Inc. | Jlladvising the target | — | $400K | $400K | DEFM14AAug 2026 |
| AstroNova, Inc.acquired by Arcline | Rockefelleradvising the target | $225Mcomputed | $4.2M | $1M | DEFM14AJul 2026 |
| Crinetics Pharmaceuticals, Inc. | J.P. Morganadvising the target | $9.02Bcomputed | $69.4M | $2M | DEFM14AJul 2026 |
| Crinetics Pharmaceuticals, Inc. | Leerink Partnersadvising the target | $9.02Bcomputed | $60.8M | $2M | DEFM14AJul 2026 |
| Dominion Energy, Inc.acquired by NextEra Energy | Goldman Sachsadvising the target | — | $47M | $5M | DEFM14AJul 2026 |
| Dominion Energy, Inc.acquired by NextEra Energy | Lazardadvising the acquirer | — | $70M | $5M | DEFM14AJul 2026 |
| Dominion Energy, Inc.acquired by NextEra Energy | BofA Securitiesadvising the acquirer | — | $30M | $5M | DEFM14AJul 2026 |
| Dominion Energy, Inc.acquired by NextEra Energy | J.P. Morganadvising the target | — | $78M | — | DEFM14AJul 2026 |
| Simulations Plus, Inc. | Morgan Stanleyadvising the target | $375Mstated | $11M | $2M | DEFM14AJul 2026 |
| Avalonbay Communities Inc.acquired by Equity Residential | Morgan Stanleyadvising the acquirer | $24.7Bstated | $50M | $5M | DEFM14AJul 2026 |
| Avalonbay Communities Inc.acquired by Equity Residential | Goldman Sachsadvising the target | $24.7Bstated | $65M | $3M | DEFM14AJul 2026 |
| Huntsman CORPacquired by Olin | Lazardadvising the acquirer | — | $24M | $5M | DEFM14AJul 2026 |
| Huntsman CORPacquired by Olin | Citiadvising the target | — | $21M | $2M | DEFM14AJul 2026 |
| Huntsman CORPacquired by Olin | Morgan Stanleyadvising the target | — | $9M | $2M | DEFM14AJul 2026 |
| Apogee Therapeutics, Inc.acquired by AbbVie | Goldman Sachsadvising the target | $10Bstated | $65M | — | DEFM14AJul 2026 |
| Apogee Therapeutics, Inc.acquired by AbbVie | Jefferiesadvising the target | $10Bstated | $65M | $2M | DEFM14AJul 2026 |
| Liveperson Inc.acquired by SoundHound | Houlihan Lokeyadvising the target | — | $1.5M | — | DEFM14AJul 2026 |
| Global Business Travel Group, Inc. | Rothschildadvising the special_committee | $4.95Bcomputed | $46M | $4M | DEFM14AJul 2026 |
| Texas Mineral Resources Corp.acquired by Usar | Roth Capital Partnersadvising the target | — | — | $350K | DEFM14AJun 2026 |
| Open Lending Corpacquired by Anv | Ftadvising the target | $236Mcomputed | $8.7M | $1M | SC 14D9Jun 2026 |
| Nuvalent, Inc. | Centerview Partnersadvising the target | $10.6Bstated | $100M | $2M | SC 14D9Jun 2026 |
| Modiv Industrial, Inc.acquired by Gnl | Truist Securitiesadvising the target | — | $2.25M | $750K | DEFM14AJun 2026 |
| Corebridge Financial, Inc.acquired by Equitable Holdings, Inc. | Morgan Stanleyadvising the target | — | $60M | $5M | DEFM14AJun 2026 |
| Corebridge Financial, Inc.acquired by Equitable Holdings, Inc. | Goldman Sachsadvising the acquirer | — | $50M | — | DEFM14AJun 2026 |
| Equitable Holdings, Inc.acquired by Corebridge Financial, Inc. | Goldman Sachsadvising the target | — | $50M | — | DEFM14AJun 2026 |
| Equitable Holdings, Inc.acquired by Corebridge Financial, Inc. | Morgan Stanleyadvising the acquirer | — | $60M | $5M | DEFM14AJun 2026 |
| Organon & Co.acquired by Sun Pharma | Morgan Stanleyadvising the target | $3.68Bcomputed | $39.4M | $4M | DEFM14AJun 2026 |
| Cross Country Healthcare Inc. | BofA Securitiesadvising the target | $428Mcomputed | $6.12M | $2M | DEFM14AJun 2026 |
| National Storage Affiliates Trustacquired by Public Storage | Morgan Stanleyadvising the target | — | $58.8M | $5M | DEFM14AJun 2026 |
| KORE Group Holdings, Inc.acquired by Searchlight | Rothschildadvising the special_committee | $700Mstated | $5M | $1.5M | DEFM14AJun 2026 |
| KORE Group Holdings, Inc.acquired by Searchlight | TD Cowenadvising the acquirer | $700Mstated | $6M | — | DEFM14AJun 2026 |
| XOMA Royalty Corp | Leerink Partnersadvising the target | $489Mcomputed | $18.4M | $1M | DEFM14AJun 2026 |
| Avanos Medical, Inc.acquired by Aip | J.P. Morganadvising the target | $4.13Mcomputed | $20M | — | DEFM14AJun 2026 |
| Catalyst Pharmaceuticals, Inc. | J.P. Morganadvising the target | $3.86Bcomputed | $61M | $3.5M | DEFM14AJun 2026 |
| Esperion Therapeutics, Inc. | Centerview Partnersadvising the target | $703Mcomputed | $37.5M | $1.5M | DEFM14AJun 2026 |
| TruBridge, Inc.acquired by Iks | Solomonadvising the target | $450Mcomputed | — | $2.5M | DEFM14AJun 2026 |
| TopBuild Corpacquired by Qxo | Goldman Sachsadvising the target | $6.4Bcomputed | $70M | — | DEFM14AMay 2026 |
| TopBuild Corpacquired by Qxo | Rbccmadvising the target | $6.4Bcomputed | $60M | — | DEFM14AMay 2026 |
| NCR Atleos Corpacquired by Brink's | J.P. Morganadvising the target | $2.21Bcomputed | $43M | $4M | DEFM14AMay 2026 |
| Sila Realty Trust, Inc.acquired by Blue Owl | BofA Securitiesadvising the target | $1.57Bcomputed | $24.9M | $2.5M | DEFM14AMay 2026 |
| Select Medical Holdings Corpacquired by Wcas | Goldman Sachsadvising the special_committee | $2.05Bcomputed | $11M | — | DEFM14AMay 2026 |
| Select Medical Holdings Corpacquired by Wcas | Wells Fargo Securitiesadvising the acquirer | $2.05Bcomputed | $11.5M | — | DEFM14AMay 2026 |
| Select Medical Holdings Corpacquired by Wcas | J.P. Morganadvising the acquirer | $2.05Bcomputed | $10M | — | DEFM14AMay 2026 |
| Whitestone REIT | Jlladvising the target | $781Mcomputed | $6.25M | — | DEFM14AMay 2026 |
| Whitestone REIT | BofA Securitiesadvising the target | $781Mcomputed | $17.5M | $2M | DEFM14AMay 2026 |
| Aes Corp | J.P. Morganadvising the target | $502Mcomputed | $75M | $4M | DEFM14AMay 2026 |
| Aes Corp | Wells Fargo Securitiesadvising the target | $502Mcomputed | $15M | $4M | DEFM14AMay 2026 |
| M3-Brigade Acquisition V Corp.acquired by ReserveOne | Lincolnadvising the special_committee | — | $550K | — | DEFM14AMay 2026 |
| KalVista Pharmaceuticals, Inc. | Centerview Partnersadvising the target | $1.08Bcomputed | $44M | $2M | SC 14D9May 2026 |
| KalVista Pharmaceuticals, Inc. | Jefferiesadvising the target | $1.08Bcomputed | $29.7M | $1.5M | SC 14D9May 2026 |
| Unifirst Corpacquired by Cintas | J.P. Morganadvising the target | $5.46Bcomputed | $42M | $5M | DEFM14AMay 2026 |
| Unifirst Corpacquired by Cintas | Goldman Sachsadvising the target | $5.46Bcomputed | $42M | $5M | DEFM14AMay 2026 |
| Green Dot Corp | Citiadvising the target | — | $13M | $3M | DEFM14AMay 2026 |
| Allbirds, Inc.acquired by American Exchange Group | TD Cowenadvising the target | $39Mstated | $2M | — | DEFM14AMay 2026 |
| Allbirds, Inc.acquired by American Exchange Group | Krolladvising the special_committee | $39Mstated | $300K | — | DEFM14AMay 2026 |
| Centessa Pharmaceuticals plcacquired by Lilly | Centerview Partnersadvising the target | — | $66M | $1.25M | DEFM14AMay 2026 |
| Centessa Pharmaceuticals plcacquired by Lilly | Jefferiesadvising the target | — | $27.6M | $1.25M | DEFM14AMay 2026 |
| Kennedy-Wilson Holdings, Inc.acquired by Fairfax Financial Holdings Limited | Moelis & Companyadvising the special_committee | $1.52Bcomputed | $33M | $2.5M | DEFM14AMay 2026 |
| Thermon Group Holdings, Inc.acquired by Ceco | Citiadvising the acquirer | $2.1Bcomputed | $17.5M | $3M | DEFM14AApr 2026 |
| Thermon Group Holdings, Inc.acquired by Ceco | Morgan Stanleyadvising the target | $2.1Bcomputed | $42.5M | — | DEFM14AApr 2026 |
| Webster Financial Corpacquired by Santander | J.P. Morganadvising the target | $7.86Bcomputed | $75M | $7.5M | DEFM14AApr 2026 |
| Soleno Therapeutics Inc. | Centerview Partnersadvising the target | $4.44Bcomputed | $40M | $2M | SC 14D9Apr 2026 |
| Soleno Therapeutics Inc. | Guggenheim Securitiesadvising the target | $4.44Bcomputed | $33M | — | SC 14D9Apr 2026 |
| Talkspace, Inc.acquired by Uhs | Wells Fargo Securitiesadvising the target | $710Mcomputed | $15.7M | $3M | DEFM14AApr 2026 |
| Urgent.ly Inc. | Pericles Capitaladvising the target | $12.1Mcomputed | $4.31M | — | SC 14D9Apr 2026 |
| Sphere 3D Corp.acquired by Cathedra | Rosenblattadvising the target | — | — | $175K | DEFM14AApr 2026 |
| Forian Inc. | Houlihan Lokeyadvising the special_committee | $65.5Mcomputed | $2.5M | $1.25M | SC 14D9Apr 2026 |
| Fonar Corp | Marshall & Stevensadvising the special_committee | $66.8Mcomputed | $120K | $120K | DEFM14AApr 2026 |
| Kezar Life Sciences, Inc. | TD Cowenadvising the target | $51.3Mcomputed | $2.5M | $1M | SC 14D9Apr 2026 |
| Enhabit, Inc.acquired by Kinderhook | Goldman Sachsadvising the target | $707Mcomputed | $24.8M | — | DEFM14AApr 2026 |
| Apellis Pharmaceuticals, Inc.acquired by Biogen | Evercoreadvising the target | $3.96Bcomputed | $76M | $2M | SC 14D9Apr 2026 |
| Clear Channel Outdoor Holdings, Inc.acquired by Mubadala Capital | Morgan Stanleyadvising the target | $1.21Bcomputed | — | $5M | DEFM14AApr 2026 |
| Clear Channel Outdoor Holdings, Inc.acquired by Mubadala Capital | Moelis & Companyadvising the target | $1.21Bcomputed | $25M | — | DEFM14AApr 2026 |
| Veris Residential, Inc. | J.P. Morganadvising the target | $1.78Bcomputed | $22M | $3M | DEFM14AApr 2026 |
| Veris Residential, Inc. | Morgan Stanleyadvising the target | $1.78Bcomputed | $17M | $1.5M | DEFM14AApr 2026 |
| Willow Lane Acquisition Corp. | Newbridgeadvising the target | — | $100K | $80K | DEFM14AApr 2026 |
| Clearwater Analytics Holdings, Inc. | PJT Partnersadvising the special_committee | $7.89Bstated | $42.2M | $5M | DEFM14AApr 2026 |
| Clearwater Analytics Holdings, Inc. | J.P. Morganadvising the target | $7.89Bstated | $51M | $5M | DEFM14AApr 2026 |
| Terns Pharmaceuticals, Inc.acquired by Merck | Centerview Partnersadvising the target | $6.69Bcomputed | $50.5M | $2M | SC 14D9Apr 2026 |
| Terns Pharmaceuticals, Inc.acquired by Merck | Jefferiesadvising the target | $6.69Bcomputed | $37M | $2M | SC 14D9Apr 2026 |
| ENVIRI Corpacquired by Veolia | BofA Securitiesadvising the target | $3.04Bstated | $46M | — | DEFM14AApr 2026 |
| European Wax Center, Inc.acquired by General Atlantic | Moelis & Companyadvising the target | — | — | $2M | DEFM14AApr 2026 |
| Marine Products Corporationacquired by MasterCraft | Wells Fargo Securitiesadvising the acquirer | $85.6Mcomputed | $4.25M | $2M | DEFM14AApr 2026 |
| Marine Products Corporationacquired by MasterCraft | Truist Securitiesadvising the target | $85.6Mcomputed | $5.5M | — | DEFM14AApr 2026 |
| Masimo Corporationacquired by Danaher | Centerview Partnersadvising the target | $9.39Bcomputed | $60M | $5M | DEFM14AApr 2026 |
| Sun Country Airlines Holdings, Inc.acquired by Allegiant | Goldman Sachsadvising the target | $218Mcomputed | $22.6M | $2M | DEFM14AMar 2026 |
| Sun Country Airlines Holdings, Inc.acquired by Allegiant | Barclaysadvising the acquirer | $218Mcomputed | — | $3M | DEFM14AMar 2026 |
| SkyWater Technology, Inc.acquired by IonQ | Goldman Sachsadvising the target | — | $33M | — | DEFM14AMar 2026 |
| Urgent.ly Inc. | Periclesadvising the target | $12.1Mcomputed | $4.31M | — | SC 14D9Mar 2026 |
| Coterra Energy Inc.acquired by Devon Energy | Goldman Sachsadvising the target | — | $37.5M | — | DEFM14AMar 2026 |
| Devon Energy Corporationacquired by Coterra Energy | Goldman Sachsadvising the other | — | $37.5M | — | DEFM14AMar 2026 |
| Farmer Bros. Co.acquired by Braemont | North Pointadvising the target | $41.5Mcomputed | $1.5M | $250K | DEFM14AMar 2026 |
| Warner Bros. Discovery, Inc.acquired by Paramount Skydance | Allen & Companyadvising the target | $68.8Bcomputed | $100M | $20M | DEFM14AMar 2026 |
| Warner Bros. Discovery, Inc.acquired by Paramount Skydance | J.P. Morganadvising the target | $68.8Bcomputed | $90M | $20M | DEFM14AMar 2026 |
| Day One Biopharmaceuticals, Inc.acquired by Servier | Centerview Partnersadvising the target | $1.34Bcomputed | $60M | $2M | SC 14D9Mar 2026 |
| DigitalBridge Group, Inc.acquired by SoftBank Group | Barclaysadvising the target | $2.19Bcomputed | — | $3M | DEFM14AMar 2026 |
| DigitalBridge Group, Inc.acquired by SoftBank Group | J.P. Morganadvising the target | $2.19Bcomputed | $28M | $3M | DEFM14AMar 2026 |
| Apollo Commercial Real Estate Finance, Inc. | BofA Securitiesadvising the target | $1.68Bstated | $8M | $3M | DEFM14AMar 2026 |
| Calavo Growers, Inc.acquired by Mission Produce | Evercoreadvising the acquirer | $486Mstated | $6.5M | $1.5M | DEFM14AMar 2026 |
| Calavo Growers, Inc.acquired by Mission Produce | Jefferiesadvising the target | $486Mstated | $12.5M | $2M | DEFM14AMar 2026 |
| SunOpta Inc. | Lazardadvising the target | $769Mcomputed | $17M | $1M | DEFM14AMar 2026 |
| Peakstone Realty Trust | BofA Securitiesadvising the target | $632Mcomputed | $16M | $2M | DEFM14AMar 2026 |
| Janus Henderson Group plc | Goldman Sachsadvising the special_committee | $7.55Bcomputed | $55M | — | DEFM14AMar 2026 |
| Udemy, Inc.acquired by Coursera | Morgan Stanleyadvising the target | — | $20M | $1M | DEFM14AMar 2026 |
| Arcellx, Inc. | Centerview Partnersadvising the target | $5.73Bcomputed | $100M | $2M | SC 14D9Mar 2026 |
| Golden Entertainment, Inc.acquired by VICI Properties | Macquarieadvising the other | $72Mcomputed | $9M | $1.25M | DEFM14AMar 2026 |
| Golden Entertainment, Inc.acquired by VICI Properties | Santanderadvising the other | $72Mcomputed | $8M | — | DEFM14AMar 2026 |
| Flushing Financial Corporationacquired by OceanFirst | Keefe, Bruyette & Woodsadvising the acquirer | $543Mstated | $7M | $1M | DEFM14AFeb 2026 |
| Flushing Financial Corporationacquired by OceanFirst | Pscadvising the target | $543Mstated | — | $750K | DEFM14AFeb 2026 |
| RAPT Therapeutics, Inc. | J.P. Morganadvising the target | $1.39Bcomputed | $50.4M | $2M | SC 14D9Feb 2026 |
| Contango ORE, Inc. |  Canaccord Genuityadvising the target | — | $4.15M | $400K | DEFM14AFeb 2026 |
| Bakkt, Inc.acquired by Dtr | Krolladvising the special_committee | — | $650K | $350K | DEFM14AFeb 2026 |
| Heritage Commerce Corpacquired by CVB Financial Corp | J.P. Morganadvising the acquirer | $811Mstated | $9M | $1M | DEFM14AFeb 2026 |
| Heritage Commerce Corpacquired by CVB Financial Corp | Piper Sandleradvising the target | $811Mstated | — | $1M | DEFM14AFeb 2026 |
| Ventyx Biosciences, Inc.acquired by Eli Lilly | Jefferiesadvising the target | $1Bcomputed | $25.7M | $2M | DEFM14AFeb 2026 |
| Ventyx Biosciences, Inc.acquired by Eli Lilly | Moelis & Companyadvising the target | $1Bcomputed | — | $2M | DEFM14AFeb 2026 |
| RAPT Therapeutics, Inc. | J.P. Morganadvising the target | $1.39Bcomputed | $50.4M | $2M | SC 14D9Feb 2026 |
| Amicus Therapeutics, Inc.acquired by BioMarin | Goldman Sachsadvising the target | $4.47Bcomputed | $52.7M | — | DEFM14AFeb 2026 |
| Amicus Therapeutics, Inc.acquired by BioMarin | Centerview Partnersadvising the target | $4.47Bcomputed | $52.7M | $2M | DEFM14AFeb 2026 |
| The Brand House Collective, Inc.acquired by Bbby | Consensusadvising the target | — | — | $150K | DEFM14AJan 2026 |
| Generation Bio Co. | TD Cowenadvising the target | — | $1.6M | $1M | SC 14D9Jan 2026 |
| Avidity Biosciences, Inc.acquired by Novartis | Goldman Sachsadvising the target | $7.84Bcomputed | $108M | $10M | DEFM14AJan 2026 |
| Avidity Biosciences, Inc.acquired by Novartis | Barclaysadvising the target | $7.84Bcomputed | — | $3.5M | DEFM14AJan 2026 |
| Diamond Hill Investment Group, Inc.acquired by First Eagle | Broadhavenadvising the target | $430Mcomputed | $7M | $1M | DEFM14AJan 2026 |
| Eventbrite, Inc.acquired by Bending Spoons S.p.A. | Allen & Companyadvising the target | — | $20M | — | DEFM14AJan 2026 |
| Alexander & Baldwin, Inc. | BofA Securitiesadvising the target | $1.54Bcomputed | $18.1M | $2.5M | DEFM14AJan 2026 |
| Trailblazer Merger Corporation Iacquired by Cyabra | Roth Capital Partnersadvising the other | $106Mstated | $175K | $175K | DEFM14AJan 2026 |
| Monroe Capital Corporation | Houlihan Lokeyadvising the special_committee | — | $1.75M | $500K | DEFM14AJan 2026 |
| First Foundation Inc.acquired by FirstSun | Stephensadvising the acquirer | $784Mstated | $8.25M | — | DEFM14AJan 2026 |
| First Foundation Inc.acquired by FirstSun | Keefe, Bruyette & Woodsadvising the target | $784Mstated | — | $2M | DEFM14AJan 2026 |
| First Foundation Inc.acquired by FirstSun | Jefferiesadvising the target | $784Mstated | $2M | $2M | DEFM14AJan 2026 |
| Olympic Steel, Inc.acquired by Ryerson | J.P. Morganadvising the acquirer | — | $8M | $3M | DEFM14AJan 2026 |
| Olympic Steel, Inc.acquired by Ryerson | KeyBancadvising the target | — | $7.5M | $1M | DEFM14AJan 2026 |
| Dynavax Technologies Corporation | Centerview Partnersadvising the target | $1.82Bcomputed | $30M | $1M | SC 14D9Jan 2026 |
| Dynavax Technologies Corporation | Goldman Sachsadvising the target | $1.82Bcomputed | $30M | $1M | SC 14D9Jan 2026 |
| Generation Bio Co. | TD Cowenadvising the target | — | $1.6M | $1M | SC 14D9Jan 2026 |
| Confluent, Inc.acquired by Ibm | Morgan Stanleyadvising the target | $9.53Bcomputed | $84M | $5M | DEFM14AJan 2026 |
| Exact Sciences Corporationacquired by Abbott | Centerview Partnersadvising the target | $19.9Bcomputed | $70M | $5M | DEFM14AJan 2026 |
| Exact Sciences Corporationacquired by Abbott | Xmsadvising the target | $19.9Bcomputed | $40M | — | DEFM14AJan 2026 |
| Brighthouse Financial, Inc.acquired by Aquarian | Goldman Sachsadvising the target | $4Bcomputed | $41M | — | DEFM14AJan 2026 |
| Brighthouse Financial, Inc.acquired by Aquarian | Wells Fargo Securitiesadvising the target | $4Bcomputed | $41M | $5M | DEFM14AJan 2026 |
| CNL Healthcare Properties, Inc.acquired by Sonida Senior Living, Inc. | RBC Capital Marketsadvising the acquirer | $1.8Bstated | $10M | $1.5M | DEFM14AJan 2026 |
| Synchronoss Technologies, Inc.acquired by Lumine Group | TD Cowenadvising the target | $104Mcomputed | $4.7M | — | DEFM14AJan 2026 |
| Crawford United Corporationacquired by Spx | Lake Streetadvising the target | $300Mstated | $2.23M | — | DEFM14AJan 2026 |
| Crawford United Corporationacquired by Spx | Stoutadvising the target | $300Mstated | $175K | $175K | DEFM14AJan 2026 |
| Veeco Instruments Inc.acquired by Axcelis Technologies | J.P. Morganadvising the acquirer | $612Mcomputed | $27.5M | $4M | DEFM14ADec 2025 |
| Veeco Instruments Inc.acquired by Axcelis Technologies | UBSadvising the target | $612Mcomputed | $28.5M | $3M | DEFM14ADec 2025 |
| Essential Utilities, Inc.acquired by American Water | BofA Securitiesadvising the acquirer | — | $45M | $2.5M | DEFM14ADec 2025 |
| Semrush Holdings, Inc.acquired by Adobe | Centerview Partnersadvising the target | $1.51Bcomputed | $33M | $5M | DEFM14ADec 2025 |
| TreeHouse Foods, Inc. | Goldman Sachsadvising the target | $1.2Bstated | $29.1M | $1.5M | DEFM14ADec 2025 |
| Qorvo, Inc.acquired by Skyworks Solutions | Goldman Sachsadvising the acquirer | — | $8M | — | DEFM14ADec 2025 |
| Qorvo, Inc.acquired by Skyworks Solutions | Centerview Partnersadvising the target | — | $74M | $6M | DEFM14ADec 2025 |
| Hologic, Inc. | Goldman Sachsadvising the target | $334Mcomputed | $109M | — | DEFM14ADec 2025 |
| REV Group, Inc.acquired by Terex | Barclaysadvising the acquirer | — | — | $4M | DEFM14ADec 2025 |
| REV Group, Inc.acquired by Terex | J.P. Morganadvising the target | — | $34M | $3M | DEFM14ADec 2025 |
| PotlatchDeltic Corporationacquired by Rayonier | Morgan Stanleyadvising the acquirer | — | $20M | $3M | DEFM14ADec 2025 |
| PotlatchDeltic Corporationacquired by Rayonier | BofA Securitiesadvising the target | — | $36M | $1.5M | DEFM14ADec 2025 |
| Civitas Resources, Inc.acquired by SM Energy | Evercoreadvising the acquirer | — | $20M | $2M | DEFM14ADec 2025 |
| Civitas Resources, Inc.acquired by SM Energy | J.P. Morganadvising the target | — | $28M | $3.5M | DEFM14ADec 2025 |
| Coeur Mining, Inc.acquired by New Gold | BMOadvising the target | — | $21M | — | DEFM14ADec 2025 |
| Coeur Mining, Inc.acquired by New Gold | Rbccmadvising the target | — | — | $4.5M | DEFM14ADec 2025 |
| Plymouth Industrial REIT, Inc.acquired by Ares Management | J.P. Morganadvising the target | $980Mcomputed | $8M | $1M | DEFM14ADec 2025 |
| Warner Bros. Discovery, Inc.acquired by Netflix | Allen & Companyadvising the target | $74.3Bcomputed | $85M | $10M | SC 14D9Dec 2025 |
| Warner Bros. Discovery, Inc.acquired by Netflix | J.P. Morganadvising the target | $74.3Bcomputed | $85M | $5M | SC 14D9Dec 2025 |
| Warner Bros. Discovery, Inc.acquired by Netflix | Evercoreadvising the target | $74.3Bcomputed | $55M | — | SC 14D9Dec 2025 |
| Kenvue Inc.acquired by Kimberly-Clark | J.P. Morganadvising the acquirer | $6.71Bcomputed | $50M | $5M | DEFM14ADec 2025 |
| Kenvue Inc.acquired by Kimberly-Clark | PJT Partnersadvising the acquirer | $6.71Bcomputed | $57M | $5M | DEFM14ADec 2025 |
| Kenvue Inc.acquired by Kimberly-Clark | Centerview Partnersadvising the target | $6.71Bcomputed | $63M | $5M | DEFM14ADec 2025 |
| Kenvue Inc.acquired by Kimberly-Clark | Goldman Sachsadvising the target | $6.71Bcomputed | $63M | — | DEFM14ADec 2025 |
| CSG Systems International, Inc. | Jefferiesadvising the target | $2.11Bcomputed | $37M | $1.5M | DEFM14ADec 2025 |
| Repare Therapeutics Inc. | Leerink Partnersadvising the target | — | $4M | $1M | DEFM14ADec 2025 |
| Forge Global Holdings, Inc.acquired by Charles Schwab | Ftadvising the target | $550Mcomputed | $11.3M | $1.25M | DEFM14ADec 2025 |
| Sotherly Hotels Inc.acquired by Kwhp | Piper Sandleradvising the special_committee | $46.1Mcomputed | $1M | — | DEFM14ADec 2025 |
| Jamf Holding Corp.acquired by Francisco Partners | Citiadvising the target | $1.74Bcomputed | $32M | $4M | DEFM14ADec 2025 |
| Mersana Therapeutics, Inc. | TD Cowenadvising the target | — | $3.5M | — | SC 14D9Dec 2025 |
| Sonim Technologies Inc. | Roth Capital Partnersadvising the special_committee | $15Mstated | $250K | — | DEFM14ADec 2025 |
| Semler Scientific, Inc.acquired by Strive | LionTreeadvising the target | — | $18M | — | DEFM14ADec 2025 |
| Cidara Therapeutics, Inc.acquired by Merck | Evercoreadvising the target | $6.96Bcomputed | $94M | $1.5M | SC 14D9Dec 2025 |
| Cidara Therapeutics, Inc.acquired by Merck | Goldman Sachsadvising the target | $6.96Bcomputed | $94M | $1.5M | SC 14D9Dec 2025 |
| Avadel Pharmaceuticals PLCacquired by Alkermes | Morgan Stanleyadvising the target | $1.22Bcomputed | $27M | $2M | DEFM14ADec 2025 |
| Avadel Pharmaceuticals PLCacquired by Alkermes | Goldman Sachsadvising the target | $1.22Bcomputed | $27M | — | DEFM14ADec 2025 |
| Anywhere Real Estate Inc.acquired by Compass | Morgan Stanleyadvising the acquirer | — | $24M | $2.5M | DEFM14ADec 2025 |
| Anywhere Real Estate Inc.acquired by Compass | Goldman Sachsadvising the target | — | $42M | $3M | DEFM14ADec 2025 |
| DENNY'S Corp | Truist Securitiesadvising the target | $640Mstated | $9.3M | $2M | DEFM14ADec 2025 |
| Comerica Inc.acquired by Fifth Third | Goldman Sachsadvising the acquirer | — | $50M | — | DEFM14ANov 2025 |
| Comerica Inc.acquired by Fifth Third | J.P. Morganadvising the target | — | $75M | $7.5M | DEFM14ANov 2025 |
| TrueCar, Inc. | Morgan Stanleyadvising the target | $227Mcomputed | $12.5M | — | DEFM14ANov 2025 |
| Electronic Arts Inc. | Goldman Sachsadvising the target | $52.4Bcomputed | $110M | — | DEFM14ANov 2025 |
| Evoke Pharma Inc | Stifeladvising the target_board | $18.9Mcomputed | $2M | $650K | SC 14D9Nov 2025 |
| Alphatime Acquisition Corp | Newbridgeadvising the target_board | $75Mstated | $150K | $50K | DEFM14ANov 2025 |
| Merus N.V.acquired by Genmab | Jefferiesadvising the target | $6.14Bcomputed | $90M | $2M | DEFM14ANov 2025 |
| Vital Energy, Inc.acquired by Crescent | Intrepidadvising the special_committee | — | — | $1M | DEFM14ANov 2025 |
| Vital Energy, Inc.acquired by Crescent | Houlihan Lokeyadvising the target | — | $15M | $3M | DEFM14ANov 2025 |
| Paramount Group, Inc. | BofA Securitiesadvising the target | $1.44Bcomputed | $34.8M | $3M | DEFM14ANov 2025 |
| Akero Therapeutics, Inc.acquired by Novo | Morgan Stanleyadvising the target | $4.45Bcomputed | $53M | $8M | DEFM14ANov 2025 |
| Akero Therapeutics, Inc.acquired by Novo | J.P. Morganadvising the target | $4.45Bcomputed | $35M | $8M | DEFM14ANov 2025 |
| Steelcase Inc.acquired by Hni | Goldman Sachsadvising the target | $879Mstated | $33M | — | DEFM14ANov 2025 |
| Steelcase Inc.acquired by Hni | J.P. Morganadvising the acquirer | $879Mstated | $17.3M | $3M | DEFM14ANov 2025 |
| Steelcase Inc.acquired by Hni | BofA Securitiesadvising the target | $879Mstated | $10.9M | $1.5M | DEFM14ANov 2025 |
| Berry Corpacquired by Crc | Guggenheim Securitiesadvising the target | — | $11M | $2.5M | DEFM14ANov 2025 |
| Heidrick & Struggles International Inc. | BofA Securitiesadvising the target | $1.35Bstated | $17.6M | $2M | DEFM14ANov 2025 |
| Tiptree Inc. | Barclaysadvising the target | $1.65Bstated | — | $3M | DEFM14AOct 2025 |
| Tiptree Inc. | BofA Securitiesadvising the target | $1.65Bstated | $9M | — | DEFM14AOct 2025 |
| WideOpenWest, Inc.acquired by DigitalBridge and Crestview | Centerview Partnersadvising the special_committee | $290Mstated | $19.4M | $2.5M | DEFM14AOct 2025 |
| ODP Corp | J.P. Morganadvising the target | $842Mcomputed | $23M | $5M | DEFM14AOct 2025 |
| Sonnet BioTherapeutics Holdings, Inc. | Chardanadvising the other | $4.8Mstated | $4M | — | DEFM14AOct 2025 |
| Sonnet BioTherapeutics Holdings, Inc. | Chardanadvising the other | $4.8Mstated | $9.64M | — | DEFM14AOct 2025 |
| Pixelworks, Inc. | Morgan Stanleyadvising the target | — | $5M | — | DEFM14AOct 2025 |
| Hanesbrands Inc.acquired by Gildan | Goldman Sachsadvising the target | — | $47M | — | DEFM14AOct 2025 |
| Hanesbrands Inc.acquired by Gildan | Evercoreadvising the target | — | $4.5M | — | DEFM14AOct 2025 |
| Premier, Inc.acquired by Patient Square Capital Fund | Goldman Sachsadvising the target | $2.32Bcomputed | $29.6M | — | DEFM14AOct 2025 |
| Premier, Inc.acquired by Patient Square Capital Fund | BofA Securitiesadvising the target | $2.32Bcomputed | $13.5M | $2M | DEFM14AOct 2025 |
| Merus N.V.acquired by Genmab | Jefferiesadvising the target | $7.34Bcomputed | $90M | $2M | SC 14D9Oct 2025 |
| Merus N.V.acquired by Genmab | Chestnutadvising the target | $7.34Bcomputed | $4M | — | SC 14D9Oct 2025 |
| CureVac N.V. | Goldman Sachsadvising the target | — | $19.7M | $1M | SC 14D9Oct 2025 |
| Verint Systems Inc. | Jefferiesadvising the target | $1.24Bcomputed | $31.8M | $2.5M | DEFM14AOct 2025 |
| Verint Systems Inc. | Evercoreadvising the target | $1.24Bcomputed | $3M | — | DEFM14AOct 2025 |
| Metsera, Inc.acquired by Pfizer | Goldman Sachsadvising the target | $5.25Bcomputed | $30M | — | DEFM14AOct 2025 |
| Metsera, Inc.acquired by Pfizer | BofA Securitiesadvising the target | $5.25Bcomputed | $10M | — | DEFM14AOct 2025 |
| Metsera, Inc.acquired by Pfizer | Guggenheim Securitiesadvising the target | $5.25Bcomputed | $30M | — | DEFM14AOct 2025 |
| Emeren Group Ltd | Krolladvising the special_committee | — | $320K | $160K | DEFM14AOct 2025 |
| Norfolk Southern Corporationacquired by Union Pacific | Morgan Stanleyadvising the acquirer | $20Bcomputed | $52.5M | $4M | DEFM14AOct 2025 |
| Norfolk Southern Corporationacquired by Union Pacific | Wells Fargo Securitiesadvising the acquirer | $20Bcomputed | $52.5M | $4M | DEFM14AOct 2025 |
| Norfolk Southern Corporationacquired by Union Pacific | BofA Securitiesadvising the target | $20Bcomputed | $130M | $7.5M | DEFM14AOct 2025 |
| 89bio, Inc. | Centerview Partnersadvising the target_board | $890Mcomputed | $33M | $1.5M | SC 14D9Oct 2025 |
| Pinnacle Financial Partners, Inc. | Centerview Partnersadvising the target_board | — | $47.5M | $5M | DEFM14ASep 2025 |
| Pinnacle Financial Partners, Inc. | Morgan Stanleyadvising the other | — | $47.5M | $5M | DEFM14ASep 2025 |
| Synovus Financial Corp. | Morgan Stanleyadvising the target | — | $47.5M | $5M | DEFM14ASep 2025 |
| Synovus Financial Corp. | Centerview Partnersadvising the other | — | $47.5M | $5M | DEFM14ASep 2025 |
| scPharmaceuticals Inc. | Leerink Partnersadvising the target | $285Mcomputed | $8.8M | $750K | SC 14D9Sep 2025 |
| Tourmaline Bio, Inc.acquired by Novartis | Leerink Partnersadvising the target | $1.23Bcomputed | $30.8M | $2M | SC 14D9Sep 2025 |
| Core Scientific, Inc.acquired by CoreWeave | Moelis & Companyadvising the target | — | — | $2M | DEFM14ASep 2025 |
| Core Scientific, Inc.acquired by CoreWeave | PJT Partnersadvising the target | — | $10M | $3M | DEFM14ASep 2025 |
| American Woodmark Corporationacquired by MasterBrand | Rothschildadvising the acquirer | — | $15M | $3M | DEFM14ASep 2025 |
| American Woodmark Corporationacquired by MasterBrand | Jefferiesadvising the target | — | $13M | — | DEFM14ASep 2025 |
| Elme Communitiesacquired by Cortland | Goldman Sachsadvising the special_committee | — | $20.8M | $2M | DEFM14ASep 2025 |
| Potbelly Corporationacquired by RaceTrac | Piper Sandleradvising the target | $409Mcomputed | $6.9M | $1M | SC 14D9Sep 2025 |
| MeridianLink, Inc.acquired by Centerbridge | J.P. Morganadvising the other | $2.39Bstated | $5M | — | DEFM14ASep 2025 |
| MeridianLink, Inc.acquired by Centerbridge | Centerview Partnersadvising the target_board | $2.39Bstated | $29.4M | $3M | DEFM14ASep 2025 |
| Augusta Gold Corp. | Nbfadvising the target | — | $1.75M | $750K | DEFM14ASep 2025 |
| STAAR Surgical Companyacquired by Alcon | Citiadvising the target_board | $1.39Bcomputed | $30.6M | $4M | DEFM14ASep 2025 |
| GSR III Acquisition Corp.acquired by Terra Innovatum Global | ERSharesadvising the target_board | $475Mstated | $75K | $60K | DEFM14ASep 2025 |
| Aris Water Solutions, Inc.acquired by Wes | Citiadvising the target | — | $20M | — | DEFM14ASep 2025 |
| Performant Healthcare, Inc.acquired by Continental | Truist Securitiesadvising the target | $715Mstated | $23.7M | $1M | DEFM14ASep 2025 |
| scPharmaceuticals Inc. | Leerink Partnersadvising the target_board | $285Mcomputed | $8.8M | $750K | SC 14D9Sep 2025 |
| Chart Industries, Inc.acquired by Baker Hughes | Wells Fargo Securitiesadvising the target_board | $10.1Bstated | $55.8M | — | DEFM14ASep 2025 |
| LAVA Therapeutics NVacquired by Xoma | Leerink Partnersadvising the target | — | $3M | $1M | DEFM14ASep 2025 |
| ZimVie Inc. | Centerview Partnersadvising the target_board | $522Mcomputed | $20M | $7.5M | DEFM14ASep 2025 |
| Goldman Sachs Middle Market Lending Corp. II | Truist Securitiesadvising the special_committee | — | $2.5M | $750K | DEFM14AAug 2025 |
| Verona Pharma plcacquired by Merck | Centerview Partnersadvising the target_board | $9.11Bcomputed | $113M | $2M | DEFM14AAug 2025 |
| Y-mAbs Therapeutics, Inc.acquired by Serb | Centerview Partnersadvising the target_board | $354Mcomputed | $9.1M | $1.5M | SC 14D9Aug 2025 |
| HilleVax, Inc. | Leerink Partnersadvising the target | $97.8Mcomputed | $3M | $1M | SC 14D9Aug 2025 |
| DallasNews Corp | J.P. Morganadvising the target | $150Mcomputed | $5M | $2.5M | DEFM14AAug 2025 |
| LAVA Therapeutics NVacquired by Xoma | Leerink Partnersadvising the target | — | $3M | $1M | SC 14D9Aug 2025 |
| AvidXchange Holdings, Inc.acquired by TPG and Corpay | Barclaysadvising the target | $2.34Bcomputed | $23M | $4M | DEFM14AAug 2025 |
| AvidXchange Holdings, Inc.acquired by TPG and Corpay | Ftadvising the target | $2.34Bcomputed | $39M | — | DEFM14AAug 2025 |
| Durect Corp | Locust Walkadvising the target | $54.3Mcomputed | — | $850K | SC 14D9Aug 2025 |
| ESSA Pharma Inc.acquired by Xrc | Leerink Partnersadvising the target | — | $2.5M | $1M | DEFM14AAug 2025 |
| Couchbase, Inc.acquired by Haveli | Morgan Stanleyadvising the target | $1.35Bcomputed | $30M | $3.5M | DEFM14AAug 2025 |
| fuboTV Inc. /FLacquired by Disney | Wells Fargo Securitiesadvising the target | — | $40M | — | DEFM14AAug 2025 |
| Mrc Global Inc.acquired by Dnow | Goldman Sachsadvising the acquirer | — | $19M | — | DEFM14AAug 2025 |
| Mrc Global Inc.acquired by Dnow | J.P. Morganadvising the target | — | $23M | $3M | DEFM14AAug 2025 |
| iTeos Therapeutics, Inc. | TD Cowenadvising the target | $385Mcomputed | $9.5M | — | SC 14D9Aug 2025 |
| Mr. Cooper Group Inc.acquired by Rocket | Citiadvising the target | $128Mcomputed | $73M | $2M | DEFM14AJul 2025 |
| SpartanNash Coacquired by C&s | BofA Securitiesadvising the target | $911Mcomputed | $23M | $2.5M | DEFM14AJul 2025 |
| Bgsf, Inc.acquired by A&M Capital Advisors | Houlihan Lokeyadvising the target | — | $2.2M | $500K | DEFM14AJul 2025 |
| Cantaloupe, Inc.acquired by 365 | J.P. Morganadvising the target | $821Mcomputed | $15M | $2M | DEFM14AJul 2025 |
| CARGO Therapeutics, Inc. | TD Cowenadvising the target | $202Mcomputed | $4.3M | — | SC 14D9Jul 2025 |
| Star Equity Holdings, Inc.acquired by Hudson | Oberonadvising the special_committee | — | $425K | $150K | DEFM14AJul 2025 |
| Enzo Biochem Inc. | BroadOakadvising the special_committee | $36.7Mcomputed | $1.75M | — | DEFM14AJul 2025 |
| Txnm Energy Inc.acquired by Blackstone Infrastructure | Wells Fargo Securitiesadvising the target | $6.45Bcomputed | $42.5M | — | DEFM14AJul 2025 |
| Sigmatron International Inc.acquired by Transom | Silvermarkadvising the target | — | $37K | — | SC 14D9Jul 2025 |
| GMS Inc.acquired by The Home Depot | Jefferiesadvising the target | $4.19Bcomputed | $47M | — | SC 14D9Jul 2025 |
| Heliogen, Inc.acquired by Zeo Energy | Pepadvising the target | — | $650K | $150K | DEFM14AJul 2025 |
| Turnstone Biologics Corp. | Leerink Partnersadvising the target | $7.87Mcomputed | $2M | $1M | SC 14D9Jul 2025 |
| Foot Locker, Inc.acquired by DICK'S Sporting Goods | Evercoreadvising the target | $2.29Bcomputed | $40M | $1M | DEFM14AJul 2025 |
| Streamline Health Solutions Inc. | Cain Brothersadvising the target_board | $23.3Mcomputed | $1.75M | $750K | DEFM14AJul 2025 |
| NV5 Global, Inc.acquired by Acuren Corporation | Robert W. Bairdadvising the target | — | — | $1.5M | DEFM14AJul 2025 |
| Charter Communications, Inc. /MO/acquired by Cox Communications (Cox Enterprises) | Citiadvising the target | — | $52.5M | $8M | DEFM14AJul 2025 |
| Charter Communications, Inc. /MO/acquired by Cox Communications (Cox Enterprises) | LionTreeadvising the target | — | $45M | $8M | DEFM14AJul 2025 |
| Sage Therapeutics, Inc.acquired by Supernus Pharmaceuticals | Goldman Sachsadvising the target_board | $452Mcomputed | $14.7M | — | SC 14D9Jul 2025 |
| Vigil Neuroscience, Inc.acquired by Sanofi | Centerview Partnersadvising the target | $93.3Mcomputed | $14.3M | $1M | DEFM14AJun 2025 |
| Verve Therapeutics, Inc.acquired by Eli Lilly and Company | Centerview Partnersadvising the target_board | $267Mcomputed | $22.5M | $2M | SC 14D9Jun 2025 |
| Verve Therapeutics, Inc.acquired by Eli Lilly and Company | Guggenheim Securitiesadvising the target | $267Mcomputed | $11.2M | — | SC 14D9Jun 2025 |
| Piedmont Lithium Inc.acquired by Sayona Mining Limited | J.P. Morganadvising the target | — | $8M | $3M | DEFM14AJun 2025 |
| Colombier Acquisition Corp. IIacquired by GrabAGun | Roth Capital Partnersadvising the target | — | $1M | — | DEFM14AJun 2025 |
| Colombier Acquisition Corp. IIacquired by GrabAGun | Btigadvising the target | — | $1.5M | — | DEFM14AJun 2025 |
Showing the first 300 rows. Use the search box to narrow the list.
Coverage: public-company targets only, because private deals do not file fee disclosures. For private sales under $150M, the calculator uses advisor survey data instead. 57 extracted fee statements failed automated quote verification and are excluded.